Distribution-based criteria for change in health-related quality of life in Parkinson's disease
Introduction
Parkinson's disease is a progressive neurodegenerative disease with wide-ranging impact on individuals. As a result, it is increasingly accepted that conventional clinical scales need to be supplemented by patient-assessed measures of health status and health-related quality of life (HRQoL). Of the range of disease-specific instruments that have been developed to assess these dimensions of outcome, the PDQ-39 is the most widely used instrument with the most extensive supportive evidence of measurement properties such as reliability, validity, and responsiveness [1], [2], [3].
A common problem in the use of health status or (HRQoL) measures in any field of health care is that the scores of instruments are unfamiliar compared to clinical scales, so that it is difficult for users to determine what constitutes a meaningful change in an instrument's score. Methods are required that improve the interpretability of such data [4], [5]. One approach to this problem, termed “distributional.” focuses upon statistical features of the data produced by an instrument [6]. One “distributional” method of assessing change in health status instruments to emerge is the “effect size” that relates data on change produced by an instrument to variance, usually in baseline data of that instrument [7].
A potentially stronger alternative approach to effect size is based on the standard error of measurement (SEM) [8], [9]. The SEM of an instrument reflects its reliability in addition to variance. It is calculated so that an SEM of zero means that an observed score is the true score. In relation to change scores the SEM estimates the extent to which observed change is true change or measurement error. Essentially, any change score above the SEM is considered likely to be a meaningful change in the specific sense of being a statistically probable change. A unique theoretic advantage claimed for the SEM is that it is sample independent, a potential advantage over the effect size.
One potential limitation of the SEM is that it is based on information about scores at a single point in time, whereas, usually, there is access to longitudinal data to assess measurement properties of HRQoL instruments. The standard error of the difference (Sdiff) is based on SEM at both time points in a longitudinal study and may, therefore, provide a more accurate estimate of the measurement error of an instrument being used to assess change [10]. The Sdiff also is the denominator in the calculation of the Reliable Change Index, which has been advocated as a statistic that determines the magnitude of change score necessary for a measure to be considered statistically reliable [11].
The focus of distributional approaches to change is assessments of whether given change scores are beyond what might occur by chance. The alternative to “distributional” approaches to identifying minimal meaningful changes in an instrument is to use “anchor-based” approaches. This alternative method relates change scores in instruments to other external patient- or clinician-derived evidence of change (hence, “anchor”), for example, changes over time in an instrument observed in respondents considered independently to have changed according to clinical scales or transition questions (e.g., how do you rate your health compared to last assessment: better, same or worse?) [12]. This approach would, therefore, for example, calculate the change scores in an instrument among respondents who separately rate themselves as changed on a transition item and consider such change scores the minimal required to count as meaningful.
This article uses the SEM and the Sdiff in relation to longitudinal data on individuals with Parkinson's disease derived from both community and clinic studies to calculate the minimum change scores required to be beyond measurement error for each of the dimensions of the PDQ-39. The minimal change scores for PDQ-39 derived from SEMs and Sdiffs were then compared to change scores observed in patients responding to retrospective transition questions based upon an anchor-based approach. The purpose of the article is to determine the extent to which there is convergence across samples and methods in identifying minimal meaningful changes for the PDQ-39.
Section snippets
Methods
Data collected from two separate studies were used to evaluate the usefulness of SEM and Sdiff criteria statistically to determine minimum meaningful changes in health status required for the PDQ-39 completed by individuals with Parkinson's disease.
A community survey of individuals with Parkinson's disease was carried out in which members of 13 branches of the Parkinson's Disease Society across England were selected and asked to participate in the study [13]. Baseline questionnaires included
Results
In the community survey of members of the Parkinson's Disease Society 851 questionnaires were returned, of which 800 had complete information and included name and address details for purposes of follow-up. At follow-up, these 800 responders were surveyed; 735 (91.9%) returned the questionnaire and 728 (91.0%) had complete data [13]. All analyses were based on the 728 respondents who had completed both the baseline and the follow-up questionnaire. The mean age of the sample was 70.4 years
Discussion
As observed in other studies, PDQ-39 scores were consistently more favorable for patients with Parkinson's disease attending clinics than respondents from a community survey, suggesting possible advantages in terms of HRQoL associated with better access to clinical services [15], [19], [20]. Despite such overall differences in HRQoL between samples, the pattern of SEM is strikingly similar for both across time periods and between samples, for all dimensions except Social Support, suggesting
References (25)
- et al.
Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life
J Clin Epidemiol
(1999) Interpreting change on the WAIS-III/WMS-III in clinical samples
Arch Clin Neuropsychol
(2001)- et al.
Determining a minimal important change in a disease-specific quality of life questionnaire
J Clin Epidemiol
(1994) - et al.
The use of the objective structured clinical examination (OCSE) for evaluation and instruction in graduate medical education
J Surg Res
(1996) - et al.
A short psychosocial questionnaire for patients with Parkinson's disease: the SCOPA-PS
J Clin Epidemiol
(2003) - et al.
The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease
Qual Life Res
(1995) - et al.
Health related quality of life in Parkinson's disease: a systematic review of disease specific instruments
J Neurol Neurosurg Psychiatry
(2002) - et al.
A review of health-related quality-of-life concepts and measures for Parkinson's disease
Qual Life Res
(1999) - et al.
Outcomes research: measuring the end results of health care
Science
(1998) - et al.
Barriers to the use of health status measures in clinical investigation, patient care, and policy research
Med Care
(1989)
Interpretation of quality of life changes
Qual Life Res
Effect sizes for interpreting changes in health status
Med Care
Cited by (47)
Development of a community-based golf and exercise program for people with Parkinson's disease
2018, Complementary Therapies in Clinical PracticeCitation Excerpt :Two participants' mobility subscale results exceeded the minimal detectable change (MDC) of 12.24 [31] and 4 participants' scores improved but did not exceed the MDC. Seven of the participants' baseline emotional well-being subscale scores were not high enough to subsequently reach the MDC (14.22) [31], however, seven participants’ post-scores for this subscale indicated improvement. The eighth participant whose QOL scores did not improve expressed satisfaction with the program due to an ability to return to playing golf.
Validation of the Kohnen Restless Legs Syndrome–Quality of Life instrument
2016, Sleep MedicineCitation Excerpt :The stability was determined by a change lower than ±3 points in the IRLS total score. This limit value was derived from two thresholds indicative of a real change: ½ standard deviation at baseline = 3.17 [28,29] and the standard error of the difference baseline–follow-up = 3.27 [30]. Weighted kappa with quadratic weighs for items and intraclass correlation coefficient (ICC, one-way, individual) for the KRLS-QoL Index were applied.
Satisfaction with Life Scale (SLS-6): First validation study in Parkinson's disease population
2016, Parkinsonism and Related DisordersMobility, mood and site of care impact health related quality of life in Parkinson's disease
2014, Parkinsonism and Related DisordersEvaluation and delivery of ambulatory rehabilitation for people with Parkinson's disease
2014, Reviews in Clinical Gerontology